Harris Eyre

Harris Eyre is an Australian neuroscientist, entrepreneur and author.https://harriseyre.com/ He is an ex Forbes 30 Under 30 Asia Listmaker and UCLA Fulbright Scholar.
In his work he incorporates insights from precision medicine, clinical care, entrepreneurship, convergence science, consumer participation, workforce development and diplomacy.
== Education ==
Dr Eyre grew up in Mackay, Queensland, Australia and completed his undergraduate medical degree (Bachelor of Medicine, Bachelor of Surgery (MBBS) with Honours) at James Cook University in North Queensland, Australia. His medical education specialized in rural, remote, Indigenous and Tropical health. He then completed his PhD in Neuroscience at the University of Adelaide.https://digital.library.adelaide.edu.au/dspace/bitstream/2440/113319/1/01front.pdf During his PhD, he was awarded the W.G. Walker Fulbright Scholarship to study at UCLA. The WG Walker Fulbright Scholarship is awarded to the top Australian Fulbright Scholar annually.
== Career ==
=== Industry ===
Harris has held a number of industry positions during his career.
He is currently President and Chief Medical Officer of PRODEO, a group of brain health-focused executives. He is also Co-Founder of The PRODEO Institute, a think-tank focused on radically approaches to advancing brain health.
Eyre was the Co-Founder and Chief Medical Officer of CNSdose, a company focused on personalized medication guidance. CNSdose is noted for incorporating blood-brain-barrier genetics into their tool and publishing a Randomized Controlled Trial. In 2016, the US Department of Veterans Affairs Health Administration noted CNSdose technology as "the most promising in an early field." CNSdose is a Texas Medical Center Venture Fund Portfolio Company.https://www.tmc.edu/news/2017/11/texas-medical-center-announces-25-million-tmc-venture-fund/. CNSdose completed the Melbourne Accelerator Program in 2016 .
=== Academic ===
Eyre published 80 + articles and chapters.
In his research career, he has co-authored numerous works including the ‘Responsible Innovation in Mental Health ’ model, ‘Mental Health Innovation Diplomacy’ model, the 'Brain Health Innovation Diplomacy' model, the 'Mars Mental Health' model, the 'Phase-specific Neuroimmune Model of Depression', a meta-analysis of chemokines in depression, a meta-analysis of pharmacogenetic-based decision support tools for depression, a randomized controlled trial of yoga to prevent dementia and the model of 'Convergence Psychiatry'.
He maintains an advisory role with Stanford’s Brainstorm Lab for Mental Health Innovation. and an honorary position with The University of Melbourne's Department of Psychiatry.
== Public and media appearances ==
His academic work has been noted in the New York Times and the Australian Financial Review.
== Awards ==
Eyre has been awarded various awards throughout his career including:
* 2020 Innovation Award for the Australian American Chamber of Commerce
* 2018 Forbes 30 Under 30 Asia Listing
* 2015 W.G. Walker Fulbright Scholar
* 2017 Victorian State Finalist for Young Australian of the Year
* 2017 Outstanding Early Career Alumni Award for the College of Medicine and Dentistry at James Cook University
* 2013 Junior Medical Officer of the Year, Australian Medical Association of Queensland 
== Works ==
=== Selected research articles ===
* H Eyre, BT Baune (2012) Neuroplastic changes in depression: a role for the immune system. Psychoneuroendocrinology 37 (9), 1397–1416
* P Siddarth, AC Burggren, HA Eyre, GW Small, DA Merrill (2018) Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults. PloS one 13 (4), e0195549
* H Eyre, A Singh, C Reynolds (2016) Tech giants enter mental health. World Psychiatry 15 (1), 21-22
* HA Eyre, W Ellsworth, E Fu, HK Manji, M Berk (2020) Responsible innovation in technology for mental health care. The Lancet Psychiatry 7 (9), 728-730 
* D Chang, E Storch, L Black, M Berk, N Pellis, H Lavretsky, J Sutton, K Ternes, M Shepanek, E Smith, R Abbott, H. Eyre (2020) Promoting Tech Transfer Between Space and Global Mental Health. Aerosp Med Hum Perform 91 (9), 737-745 
== References ==
Category:Australian neuroscientists
Category:Australian writers
Category:Australian medical doctors